Fonterra provides update on divestment of Soprole

TRANSACT
Thu, Feb 23 2023 08:30 am

23 February 2023

Fonterra provides update on divestment of Soprole

Fonterra has today provided an update on the sale of its Chilean Soprole business to Gloria Foods - JORB S.A. (Gloria Foods).

As announced in November 2022, the sale is subject to a number of conditions, including the receipt of approval from the competition authority in Chile.

CEO Miles Hurrell says he’s pleased to confirm approval from the competition authority, Fiscalía Nacional Económica (FNE), has now been received.

“Completion of the sale remains subject to satisfaction of other conditions previously announced, including commencement of an irrevocable public tender offer process in Chile for the outstanding shares in Soprole not already owned by Fonterra.

“Receipt of FNE approval is a significant milestone for the transaction and we remain on track in the sale process. We will update the market on expected timing for completion of the sale as the remaining conditions are progressed,” says Mr Hurrell.

Fonterra remains committed to targeting a significant capital return to our shareholders and unitholders. The Fonterra Board intends to make a final decision on the amount and timing of any capital return once the sale agreement is unconditional, cash proceeds are received in New Zealand and having regard to other relevant factors including Fonterra’s debt and earnings outlook at such time.

ENDS

For further information contact:

Fonterra Communications
24-hour media line
Phone: +64 21 507 072


Announcement PDF


Markets News

Economic hedges help ANZ NZ lift annual profit
Finance

Economic hedges help ANZ NZ lift annual profit

ANZ NZ styles its full-year results as solid as net-interest margin nudges higher.

Markets

PaySauce shares rise as it eyes Australia

Customer numbers for micro and rural payroll firm increased 9% for six months to Sept 30.

PaySauce shares rise as it eyes Australia
Markets

Vital Healthcare taking property portfolio management in-house

The NZX-listed company has announced a $220m capital raise to fund the transition.

Vital Healthcare taking property portfolio management in-house